Headquarters
101 W DICKMAN ST STE 200, BALTIMORE, MD 21230-5007, US
BALTIMORE, MD, US
ALETIRA THERAPEUTICS INCORPORATED
From the company
Aletira is developing gene therapies that use alternative splicing to control where gene expression occurs. Its selective exon, SELEXON(TM), technology harnesses alternative splicing to enable cell-type selective gene expression in therapeutic constructs. SELEXONs can be incorporated into any gene therapy platform (e.g., AAV) to ensure gene products are expressed in target cells and avoid off-target expression, improving safety, increasing potency, and accelerating development.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.